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OBJECTIVE: The present study was designed to further investigate the effect of amitriptyline, a classical tricyclic
antidepressant, on carrageenan-induced paw edema in rats.
METHODS: First, amitriptyline was administered intraperitoneally (i.p.) at doses of 20, 40 and 80 mg kg-1, 30 min
before subplantar injection of carrageenan. Second, amitriptyline was given intracerebroventriculary or
intrathecally at doses of 25, 50 and 100 mg/rat, 30 min prior to carrageenan challenge. Third, the effect of
adrenergic receptor antagonists such as propranolol (10 mg kg-1, i.p.), prazosin (4 mg kg-1, i.p.) and yohimbine
(10 mg kg-1, i.p.) and an opioid receptor antagonist (naloxone, 4 mg kg-1, i.p.) on the anti-inflammatory effect of
amitriptyline (40 mg kg-1, i.p.) was investigated.
RESULTS: Our data confirm that intraperitoneally administered amitriptyline exhibits a marked anti-inflammatory
effect on carrageenan-induced paw edema in rats 4 h postcarrageenan challenge (P , 0.001).
Intracerebroventricular (i.c.v.) administration of amitriptyline also reduced the development of paw edema at 4 h
postcarrageenan (P , 0.001), but intrathecal (i.t.) application of amitriptyline failed to alter the degree of paw
swelling. Furthermore, the applied antagonists did not modify the anti-inflammatory effect of amitriptyline.
CONCLUSION: These results support the view that amitriptyline has a considerable anti-inflammatory effect on
carrageenan-induced paw edema in rats and suggest that at least a part of this property could be mediated through
supraspinal sites. Moreover, it seems unlikely that the investigated adrenergic and opioid receptors have a
significant role in this effect of amitriptyline.
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INTRODUTION
Antidepressants, particularly conventional tricyclic anti-
depressants (TCAs) such as amitriptyline, nortriptyline, and
doxepin, are commonly prescribed for alleviating various
types of pain, involving both inflammatory (rheumatoid
arthritis and fibromyalgia) and neuropathic pain (neuro-
pathic pain and postherpetic neuralgia), besides their use in
the treatment of mood disorders.1–3
Recently, the anti-inflammatory effects of some antide-
pressants such as fluoxetine, trazodone, and desipramine,
have been established in several experimental models of
inflammation.4–7 Imipramine and clomipramine induce
apoptosis in human lymphocytes, and fluoxetine suppresses
lymphocyte proliferation in a dose-dependent manner.8,9
These findings warrant more research into the anti-
inflammatory effect of antidepressants for a number of
reasons. First, the exact mechanism of analgesic activity of
antidepressant medications is not completely understood.
Thus, a greater knowledge of the anti-inflammatory effects
of antidepressants may result in better insights into their
antinociceptive mechanisms. Second, the etiology of depres-
sion is not well understood, and some studies suggest that
dysregulation in the immune system functioning and the
secretion of proinflammatory cytokines such as interleukin
(IL)-1 and tumor necrosis factor (TNF)-a may have a
significant role in the pathogenesis of major depression.10
Therefore, if antidepressants alter the function of immune
system, this effect may represent a new prospect for
explaining the efficacy of antidepressants in the treatment
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of major depression.11–14 Third, major depression is a com-
mon disorder in the general population and is even more
common in people who are suffering from inflammatory
diseases such as Crohn’s disease and asthma.15,16 Thus,
information about the anti-inflammatory activities of anti-
depressants would be useful for determining the best drug
in these situations.
Amitriptyline, a dual serotonergic and noradrenergic
reuptake inhibitor (SNRI), is widely used in the manage-
ment of major depression and different types of pain,
including neuropathic pain or migraines.17-21 Abdel-Salam
and co-workers found that amitriptyline produces an anti-
inflammatory effect on carrageenan-evoked paw swelling in
rats,4 but there is no information about the sites of this
action. Therefore, the purpose of the present study was to
investigate the anti-inflammatory properties of amitripty-
line further and to understand the function of central sites in
these actions. We also tried to determine the possible
involvement of some adrenergic and opioid receptors in the
anti-inflammatory effect of amitriptyline, using the antago-
nists of these receptors.
MATERIALS AND METHODS
Chemical
Amitriptyline hydrochloride was donated by Iran Daru
Pharmaceutical Co. (Tehran, Iran) and was dissolved in
isotonic saline. Carrageenan was purchased from Fluka
Chemical (Switzerland) and was also dissolved in isotonic
saline. Indomethacin (Sigma, USA) was suspended in
aqueous carboxy methylcellulose (2% w/v). Propranolol,
prazosin, yohimbine (Sigma, USA), and naloxone (Tolid
Drau Co., Tehran, Iran), were dissolved in isotonic saline.
Animals
Male Wistar rats (200–250 g) were obtained from the
animal house of the Faculty of Pharmacy, Isfahan University
of Medical Sciences, Iran. Animals were housed in standard
polypropylene cages, four per cage, under a 1212 h light/
dark cycle with free access to food and water. Following
surgical implantation of an i.c.v. cannula, animals were
housed one per cage to avoid possible dislocation of the
cannula. The experiments were carried out in accordance
with local guidelines for the care of laboratory animals of
the Isfahan University of Medical Sciences.
Surgical procedures
The animals were anesthetized with i.p. injection of a
ketamine (50 mg kg-1) and xylazine (10 mg kg-1) mixture. Then,
the animals were placed in a stereotaxic frame (Stoelting,
USA), and an i.c.v. cannula was implanted with stereotaxic
coordinates: Anterior-posterior (AP), -0.8 mm; L, 1.4 mm; and
V, 3.3 mm, according to Paxinos and Watson.22 The animals
were handled daily for five days before the experiment to
acclimatize them to manipulation and minimize nonspecific
stress responses. Rats with the i.c.v. cannulas were euthanized
at the end of the experiments, and their brains were examined
to confirm the correct implantation of the cannula.
Intrathecal injection
Drug injections at the lumbar level of the spinal cord were
performed according to the method previously described by
Mestre et al.23 Briefly, the animals were gently constrained by
the hands of experimenter, and a 27-gauge needle was
carefully inserted between the L5-L6 spaces. A flick of the tail
indicated that the spinal cord channel was reached, and the
injections were given in a volume of 10 ml. As a rule, we did
not try the spinal injection twice, and the animals that did not
show the tail reflex at the first injection effort were discarded.
All intrathecal injections of amitriptyline or vehicle (control
group) were made 30 min before the carrageenan injection.
Carrageenan-induced paw edema
The rats received a subplantar injection of 100 ml of a 1%
(w/v) suspension of carrageenan lambda in the right hind
paw.24 The volume of the paw was measured by a
Plethysmometer (Ugo Basile, Italy) immediately prior to
carrageenan injection and then 4 h afterwards. The data
were expressed as the variation in the paw volume (ml) and
were compared to preinjection values.
Experimental design
In the first series of experiments, the effect of i.p.
amitriptyline (20, 40 and 80 mg kg21, n = 6) on paw edema
was studied. Amitriptyline was given 30 min before
subplantar injection of carrageenan. The control group
received only vehicle (n = 6; i.p.). A group of animals that
was pretreated with indomethacin (n = 6; 10 mg kg-1) was
used as the positive control.
In the second series, we used the i.c.v. route to evaluate
the possible involvement of the supraspinal level in the anti-
inflammatory effect of amitriptyline. The drug was admi-
nistered smoothly for 1 min through the injection cannula
(25, 50 and 100 mg per rat, n = 8) 30 min prior to
carrageenan in a volume of 10 ml. The control group
received vehicle (n = 8; i.c.v).
In the third series, amitriptyline was injected into the
space between L5-L6 (25, 50 and 100 mg per rat, n = 6)
30 min prior to carrageenan in a volume of 10 ml. The control
group received vehicle (n = 6; i.t.).
In the fourth series of experiments, we assessed the
possible involvement of opioid and some important
adrenergic receptors in the inhibitory activity of amitripty-
line on carrageenan-induced paw edema. The animals were
pretreated with propranolol (10 mg kg-1, i.p., a nonselective
b-adrenoreceptor antagonist), yohimbine (10 mg kg-1, i.p.,
an a2-adrenoreceptor antagonist) and prazosin (4 mg kg
-1,
i.p., an a1-adrenoreceptor antagonist) 30 min prior to i.p.
injection of amitriptyline (40 mg kg-1). Naloxone (4 mg kg-1,
i.p., a nonselective opioid receptor antagonist) was coadmi-
nistrated with amitriptyline. These doses were chosen based
on previous studies.25–27
Statistical analysis
The data are expressed as the means ¡ S.D. The
differences between the control and treatment groups were
tested by one-way analyses of variance (ANOVA) followed
by the Tukey post-hoc test, using SPSS 13.0 software. A
probability of P, 0.05 was used as the significance thresh-
old for all comparisons.
RESULTS
Effect of i.p. injection of amitriptyline on
carrageenan-induced paw edema
As illustrated in Figure 1, i.p. injection of amitriptyline at
doses of 40 and 80 mg kg-1 significantly inhibited the
development of paw edema 4 h after the induction of
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inflammation (P , 0.001) as compared to the control group.
As expected, the reference drug, indomethacin (10 mg kg-1),
caused a significant inhibition of edema 4 h post-carragee-
nan (P , 0.001).
Effect of i.c.v. injection of amitriptyline on
carrageenan-induced paw edema
As shown in Figure 2, i.c.v. application of amitriptyline
(25, 50 and 100 mg per rat) produced a noticeable inhibitory
effect on paw edema formation in a dose-dependent manner
(P , 0.001) as compared to the control group.
Effect of i.t. injection of amitriptyline on
carrageenan-induced paw edema
As illustrated in Figure 3, i.t. administration of amitripty-
line through the i.c.v. route (25, 50 and 100 mg per rat)
did not cause any change in the paw edema 4 h post-
carrageenan as compared to the control group.
Effect of propranolol, yohimbine , prazosin and
naloxone on the anti-inflammatory effect of
amitriptyline
As shown in Figure 4, the pretreatment of animals with
propranolol (10 mg kg-1, i.p.), yohimbine (10 mg kg-1, i.p.),
and prazosin (4 mg kg-1, i.p.) 30 min prior to amitriptyline
(40 mg kg -1, i.p.) did not alter the anti-inflammatory activity
of amitriptyline. Additionally, coadministration of naloxane
(4 mg kg-1, i.p.) with amitriptyline (40 mg kg -1, i.p.) did not
modify the inhibitory effect of amitriptyline on the degree of
paw swelling.
DISCUSSION
In the present study, we confirmed that i.p. injection of
amitriptyline produces a noticeable anti-inflammatory effect
on carrageenan-induced paw edema in rats, and this effect
was found to be comparable to that observed with the
Figure 1 - Effect of i.p. injection of amitriptyline on carrageenan-
induced paw edema in rats. Amitriptyline (20, 40 and 80 mg kg-1),
indomethacin (10 mg kg-1) and the vehicle were administrated
30 min prior to carrageenan (1%) injection, and the rats were
evaluated for paw edema 4 h post-carrageenan injection. The
values represent the mean variation in the paw volume ¡ S.D.
(n = 6, *** P , 0.001). Ind: indomethacin.
Figure 2 - Effect of intracerebroventricular injection of amitripty-
line on carrageenan-induced paw edema in the rats.
Amitriptyline or the vehicle was administrated 30 min prior to
carrageenan (1%) injection, and the rats were evaluated for paw
edema 4 h post-carrageenan injection. The values represent the
mean variation in the paw volume¡ S.D. (n = 8, * P , 0.05, *** P
, 0.001).
Figure 3 - Lack of effect of intrathecal injection of amitriptyline
on carrageenan-induced paw edema in the rats. Amitriptyline or
the vehicle was administrated intrathecally 30 min prior to
carrageenan (1%) injection, and the rats were evaluated for paw
edema 4 h post-carrageenan. The values represent the mean
variation in the paw volume ¡ S.D. (n = 6).
Figure 4 - Effect of pretreatment with yohimbine (10 mg kg -1),
prazosin (4 mg kg -1) and propranolol (10 mg kg -1) on the anti-
inflammatory activity of amitriptyline (40 mg kg-1). Naloxone
(4 mg kg -1) was coadministrated with amitriptyline (40 mg kg-1).
The values represent the mean variation in the paw volume ¡
S.D. (n = 6, *** P , 0.001). ami: amitriptyline.
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reference drug indomethacin. Our results are in good
agreement with the research of Abdel-Salam and co-work-
ers,4 although, in our study, the anti-edematogenic effect of
amitriptyline was observed at higher doses than in the
earlier study, a fact that may be due to the different
experimental conditions used.
The well-known theory of the antidepressive effect of
amitriptyline states that the drug modulates the synaptic
concentrations of monoamine neurotransmitters such as
norepinephrine and serotonin in the central nervous system
(CNS).28,29 Therefore, an important aspect investigated
herein was the possible involvement of central sites in the
anti-inflammatory effect of amitriptyline. Our results
revealed that i.c.v. application of amitriptyline is effective
in reducing inflammation in a dose-dependent manner.
Indeed, this is the first work to show that i.c.v injection of
amitriptyline produces an anti-inflammatory effect in
experimental models of inflammation. In this context, in
our previous study, we found that i.c.v. injection of
maprotiline, an atypical antidepressant acting as a selective
norepinephrine reuptake inhibitor, reduces the develop-
ment of paw edema in rats.30 Thus, it seems plausible that
supraspinal sites have an important role in the anti-
inflammatory properties of antidepressant medications.
Furthermore, the anti-inflammatory effect observed after
i.c.v. injection of amitriptyline could not be attributed to
diffusion of the drug from the central sites into peripheral
sites because the doses of amitriptyline that were effective
via the i.c.v. route were not able to suppress paw swelling
after i.p. injection (data not shown).
In several studies, it has been reported that the spinal cord
is a site for modulation of neurogenic elements of peripheral
inflammation,31,32 but in this study, the spinal pretreatment
of animals with the doses of amitriptyline that were
effective in reducing paw edema via i.c.v. application failed
to alter the development of paw edema. Thus, it seems
unlikely that the spinal levels participate in this effect of
amitriptyline. Consistent with this finding, Sawynok and
Reid reported that i.t. administration of amitriptyline does
not influence the paw edema produced by injection of
formalin into the hind paw in rats.33
The underlying mechanisms by which antidepressants
reduce inflammation remain unknown, although it has been
suggested that the suppression of some inflammatory
mediators such as substance P (SP) and prostaglandin E2
might participate in the anti-inflammatory effects of
clomipramine and fluoxetine.5 Abdel-Salam et al. found
that the anti-inflammatory effect of fluoxetine, as a selective
serotonin reuptake inhibitor (SSRI) antidepressant, is par-
tially reduced by coadministration of naloxone.25 Because it
has been well established that amitriptyline interacts with
opiate receptors to generate some of its therapeutic effects,
especially its analgesic activities, 34,35 we evaluated the role
of opioid receptors in the anti-inflammatory activity of
amitriptyline. In this regard, the inhibitory effect of
amitriptyline on paw edema was not influenced by the
coadministration of naloxone, indicating that opioid recep-
tors are not involved in this effect of amitriptyline.
Moreover, there is evidence that the anti-inflammatory
effect of TCA drugs can be attributed to their ability to
potentiate adrenergic transmission,36 but in our experimental
conditions, the pretreatment of animals with some adrenergic
receptor antagonists, including propranolol, yohimbine and
prazosin, did not modify the anti-inflammatory effect of
amitriptyline. Thus, these observations did not provide a link
between the anti-inflammatory action of amitriptyline and
some important adrenergic receptors.
Indeed, in our experimental conditions, i.p. injection of
amitriptyline at doses of 40 or 80 mg kg-1 produced a
marked sedation in the animals. It has been established that
sedation can suppress the function of the immune system in
several ways.37 Therefore, the sedative effect of amitripty-
line may contribute to its anti-inflammatory effect.
Finally, it is worth mentioning that carrageenan-induced
paw edema is a well-known model of acute inflammation
that includes biphasic phases and a number of mediators
participate in the inflammatory response elicited by
carrageenan.38,39 On the other hand, amitriptyline is a
pleiotropic tricyclic antidepressant that interacts with
histaminic, cholinergic, serotonin, and N-methyl-D-aspar-
tate (NMDA) receptors, biogenic amines, and substance P in
addition to inhibiting norepinephrine and serotonin reup-
take.40,41 Therefore, based on these facts, there are a variety
of putative sites at which amitriptyline may exert its anti-
inflammatory action.
In summary, our results verify the findings of Abdel-
Salam et al. regarding the anti-inflammatory effect of
amitriptyline in an acute model of inflammation4 and
demonstrate that the supraspinal sites have an important
role in this effect of amitriptyline, while ruling out the
possible participation of opioid and some important
adrenergic receptors in this effect. Therefore, this study
not only extends our knowledge about the anti-inflamma-
tory effect of amitriptyline but also provides new insights
into the central mechanisms involved in the anti-inflamma-
tory effects of antidepressants.
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